Blood Test Can Identify Prostate Cancer Patients Who Are Not Likely to Respond to EnzalutamideAlice Goodman
Dr. Jon Burrows, Chief Executive Officer at Oxford Biodynamics said, "There is a clear need in everyday clinical practice for a highly accurate blood test that can screen men for prostate cancer and accurately identify those at risk, while sparing those who up to now would be subject to unn...
"Our results introduce a new paradigm for the management of patients with advanced prostate cancer. In the future, we hope to routinely monitor genetic mutations in patients with advanced disease using just a blood test – enabling us to stop treatments when they become disease drivers and select...
GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data ...
The Galleri multi-cancer early detection test is a proactive tool to screen for cancer. With a simple blood draw, the Galleri test can identify DNA shed by cancer cells, which can act as a unique “fingerprint” of cancer, to help screen for some ...
Electrophoresis is a test that examines various proteins in the blood. This can help identify various immunoglobulins, which are elevated in people with multiple myeloma. A bone marrow biopsy may help confirm the diagnosis of blood cancer. Complete blood count (CBC) A complete blood count helps ...
Just being able to identify the presence of genetic markers isn’t the same as ensuring better outcomes for patients, and this research makes that clear as part of a suggested roadmap for what’s next. Over-treatment of early breast cancers and prostate cancers has subjected patients to what...
A study published in the British Medical Journal this month found that routine screening for prostate cancer through a PSA test does more harm than good, because it can produce false positives, or lead to the overtreatment of cancers that were never likely to cause problems or be fatal. A ...
provides that link and, with it, glimpses into the future of oncology practice. It defines an approach to identify mechanisms that are associated with tumor cells evading drug treatment for men with castration-resistant prostate cancer that is resistance to abiraterone, all with a blood test....
A groundbreaking study has revealed advancements in lung cancer detection using an ultra-sensitive personalized test designed to identify even the smallest traces of circulating tumor DNA (ctDNA) in the blood of cancer patients and survivors. More... Visit expo >...